What is the cost of disease progression among patients with indolent or aggressive non-Hodgkin lymphoma (NHL)? Meeting Abstract


Authors: Engel-Nitz, N.; Byfield, S. D.; Bancroft, T.; Amy, A. J.; Reyes, C.; Chen, M.; Matasar, M. J.
Abstract Title: What is the cost of disease progression among patients with indolent or aggressive non-Hodgkin lymphoma (NHL)?
Meeting Title: 58th Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 128
Issue: 22
Meeting Dates: 2016 Dec 3-6
Meeting Location: San Diego, CA
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2016-12-02
Language: English
ACCESSION: WOS:000394452706035
PROVIDER: wos
DOI: 10.1182/blood.V128.22.5957.5957
Notes: Meeting Abstract: 5957 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Matthew J Matasar
    289 Matasar